tert-Butyl 4-(2-chloroethyl)piperazine-1-carboxylate

Catalog No. :
ACRLAW467
CAS No. :
208167-83-3
Molecular Formula :
C11H21ClN2O2
Molecular Weight :
248.75

IUPAC Name:tert-butyl 4-(2-chloroethyl)piperazine-1-carboxylate

tert-Butyl 4-(2-chloroethyl)piperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$120.00Login to see priceIn stockInquiry
100g98%$396.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(2-chloroethyl)piperazine-1-carboxylate
IUPAC Nametert-butyl 4-(2-chloroethyl)piperazine-1-carboxylate
MDL No.T191995
Molecular FormulaC11H21ClN2O2
Molecular Weight248.75
SMILESO=C(N1CCN(CCCl)CC1)OC(C)(C)C
InChI KeyMYOWELLYEZMECA-UHFFFAOYSA-N
Synonym208167-83-3 | tert-Butyl 4-(2-Chloroethyl)piperazine-1-carboxylate | 1-Boc-4-(2-chloroethyl)piperazine | TERT-BUTYL 4-(2-CHLOROETHYL)TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE | 1-Piperazinecarboxylic acid, 4-(2-chloroethyl)-, 1,1-dimethylethyl ester | MFCD08443993 | SCHEM
CAS No.208167-83-3
PubChem CID22106269

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACRLAW467 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRLAW467 route product structure diagram
    ACRLAW467208167-83-3 In Stock
Inquiry

2. ACRLAW467 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAUEW509 route compound structure diagram
    ACAUEW50953502-60-6 In Stock
  4. Then
  5. ACRLAW467 route product structure diagram
    ACRLAW467208167-83-3 In Stock
Inquiry

Comments (0)